Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

      Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

      Farhat Nasim26 Feb 2019 9:50 AM IST
      The company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
      Shilpa Medicare gets tentative USFDA nod for Dimethyl Fumarate delayed release capsules

      Shilpa Medicare gets tentative USFDA nod for Dimethyl Fumarate delayed release capsules

      Farhat Nasim26 Feb 2019 9:40 AM IST
      Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Dimethyl Fumarate delayed-release capsules is approximately USD...
      Diabetics, insuline providers stockpile over Brexit fears

      Diabetics, insuline providers stockpile over Brexit fears

      Farhat Nasim26 Feb 2019 8:59 AM IST
      A no-deal Brexit would almost certainly mean re-establishing customs and health controls, which could lead to delays at the border.London: Diabetics...
      Pharmaceutical residues in fresh water pose environmental risk

      Pharmaceutical residues in fresh water pose environmental risk

      Farhat Nasim25 Feb 2019 1:07 PM IST
      Washington: A new research now finds that over the past two decades, concentrations of pharmaceuticals have increased in freshwater sources all over...
      U.S. Senators launch bipartisan probe into rising insulin prices

      U.S. Senators launch bipartisan probe into rising insulin prices

      Farhat Nasim25 Feb 2019 1:07 PM IST
      WASHINGTON: Two top U.S. senators launched an investigation into rising insulin prices on Friday, sending letters to the three leading manufacturers...
      Kerala: Government MCHs faces acute shortage of pharmacists

      Kerala: Government MCHs faces acute shortage of pharmacists

      Farhat Nasim24 Feb 2019 10:00 AM IST
      After the breakup of the Directorate of Health Services to form the DME in 2008-09, no new posts of pharmacists have been created. Non-permanent staff...
      Biocon chief Kiran Shaw says it

      Biocon chief Kiran Shaw says it's a struggle to find adequate number of women for leadership roles

      Farhat Nasim23 Feb 2019 10:00 AM IST
      "Over the next five to ten years we will hopefully see many more women playing leadership roles. Yes, things are happening but not at the pace that I...
      Zydus receives USFDA nod for Phytonadione, Colchicine tablets

      Zydus receives USFDA nod for Phytonadione, Colchicine tablets

      Farhat Nasim23 Feb 2019 9:45 AM IST
      Zydus has received final approval from the United States Food and Drug Administration (USFDA) to market generic Phytonadione tablets USP in the...
      Dr Reddys recalls 2770 bags of Levetiracetam Sodium Chloride injection in US market

      Dr Reddys recalls 2770 bags of Levetiracetam Sodium Chloride injection in US market

      Farhat Nasim22 Feb 2019 11:53 AM IST
      As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Dr Reddys is recalling Levetiracetam in 0.54 per cent Sodium...
      Lupin recalls 43860 bottles of Moxifloxacin Ophthalmic solution in US over impurities

      Lupin recalls 43860 bottles of Moxifloxacin Ophthalmic solution in US over impurities

      Farhat Nasim22 Feb 2019 9:45 AM IST
      Lupin is recalling 43,860 bottles (3ml) due to failed impurities or degradation specifications, United States Food and Drug Administration (USFDA)...
      Dr Reddys re-launches Buprenorphine, Naloxone Sublingual Film in US market

      Dr Reddy's re-launches Buprenorphine, Naloxone Sublingual Film in US market

      Farhat Nasim21 Feb 2019 12:34 PM IST
      The re-launch comes on the heels of a favourable ruling in patent litigation by the United States Court of Appeals for the Federal Circuit.Hyderabad:...
      Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

      Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules

      Farhat Nasim21 Feb 2019 9:45 AM IST
      Acetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok